+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiac Marker Testing Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Technology; Application; and End-User- Product Image
Cardiac Marker Testing Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Technology; Application; and End-User- Product Image
New

Cardiac Marker Testing Market Size and Forecasts 2020-2030: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product; Technology; Application; and End-User

  • PDF Icon

    Report

  • 112 Pages
  • August 2024
  • Region: Global
  • IHR Insights
  • ID: 5995363
10% Free customization
Description Jump to:
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
This report provides a detailed analysis of the global cardiac marker testing market from 2020 to 2030. It includes insights into market dynamics, key trends, drivers, challenges, and opportunities, as well as a comprehensive analysis of market segmentation by product, technology, application, end-user, and region.

Market Dynamics:

1. Key Market Drivers:

  • Increasing Incidence of Cardiovascular Diseases: Rising rates of cardiovascular diseases are driving demand for cardiac marker testing.
  • Technological Advancements: Innovations in cardiac marker testing technologies are enhancing accuracy and efficiency.

2. Key Market Challenges:

  • High Costs of Advanced Technologies: The cost of advanced cardiac marker testing instruments can be a barrier to widespread adoption.
  • Regulatory Compliance: Navigating regulatory requirements for cardiac marker testing products can be complex.

Market Trends:

  • Integration of Automation and AI: The use of automation and AI in cardiac marker testing is improving testing workflows and accuracy.
  • Growth in Point-of-Care Testing: Expansion of point-of-care cardiac marker testing solutions is providing rapid and on-site testing capabilities.

Market Size Estimation

The global cardiac marker testing market is projected to reach USD 10 billion by 2030, growing at a CAGR of 8% from 2024 to 2030. This growth is driven by increasing cardiovascular disease prevalence, advancements in testing technologies, and rising demand for rapid diagnostic solutions.

Market Segmentation:

1. By Product:

  • Instruments: Includes diagnostic machines and analyzers for cardiac marker testing.
  • Reagents: Covers test reagents and consumables used in cardiac marker testing.
  • Consumables: Includes items such as sample collection devices and other disposable products.
  • Software: Involves diagnostic software and data management tools.

2. By Technology:

  • Immunoassays: Techniques for detecting cardiac biomarkers using antibody-based methods.
  • Molecular Diagnostics: Advanced methods for measuring cardiac biomarkers using molecular techniques.
  • Others: Includes additional cardiac marker testing technologies and methods.

3. By Application:

  • Acute Myocardial Infarction: Testing for biomarkers related to heart attacks and acute coronary syndromes.
  • Heart Failure: Testing for biomarkers associated with heart failure conditions.
  • Risk Assessment: Assessing cardiovascular risk through biomarker testing.
  • Others: Includes other applications such as post-surgical monitoring and management.

4. By End-User:

  • Hospitals: Utilize cardiac marker testing solutions for patient care and cardiovascular disease management.
  • Diagnostic Laboratories: Specialized facilities providing cardiac marker testing services.
  • Cardiology Clinics: Clinics focused on diagnosing and treating cardiovascular conditions.
  • Others: Includes research institutes and public health organizations.

5. By Region:

  • North America: Leading in market size due to advanced healthcare infrastructure and high prevalence of cardiovascular diseases.
  • Europe: Significant growth driven by technological advancements and regulatory support.
  • Asia Pacific: High growth potential due to increasing healthcare access and rising cardiovascular disease rates.
  • Latin America: Steady growth influenced by improving healthcare infrastructure and diagnostic capabilities.
  • Middle East and Africa: Growth driven by expanding healthcare infrastructure and increased focus on cardiovascular disease management.

Competitive Landscape

Key players in the cardiac marker testing market include:

  • Roche Diagnostics: Provides a range of cardiac marker testing instruments and reagents.
  • Abbott Laboratories: Known for its advanced cardiac marker testing solutions.
  • Siemens Healthineers: Offers diagnostic instruments and reagents for cardiac marker testing.
  • Beckman Coulter: Specializes in cardiac marker testing technologies and solutions.
  • Ortho Clinical Diagnostics: Provides a variety of cardiac marker testing products and technologies.

Market Forecast

The cardiac marker testing market is expected to experience significant growth, driven by increasing cardiovascular disease prevalence, technological advancements, and the rising demand for rapid and accurate diagnostic solutions. Integration of automation and AI is expected to contribute to market expansion.

Regulatory Framework

The market operates under stringent regulatory oversight from organizations such as the FDA in the United States and the EMA in Europe, ensuring the safety, efficacy, and quality of cardiac marker testing products.

Customer Landscape

The market serves a diverse customer base, including hospitals, diagnostic laboratories, cardiology clinics, and research institutes. Each segment has specific needs and requirements for cardiac marker testing solutions.

Regional Analysis

North America leads the market due to its advanced healthcare infrastructure and high prevalence of cardiovascular diseases, while Asia Pacific is anticipated to experience the highest growth rate due to increasing healthcare access and rising cardiovascular disease rates.

Table of Contents

1. Executive Summary
2. Market Introduction
2.1. Market Definition
2.2. Market Segmentation
2.3. Research Methodology
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Global Cardiac Marker Testing Market, by Product
4.1. Assays
4.2. Instruments
4.3. Reagents
4.4. Others
5. Global Cardiac Marker Testing Market, by Marker Type
5.1. Troponin
5.2. B-Type Natriuretic Peptide (BNP)
5.3. Creatine Kinase-MB (CK-MB)
5.4. Myoglobin
5.5. Others
6. Global Cardiac Marker Testing Market, by End-User
6.1. Hospitals
6.2. Diagnostic Laboratories
6.3. Clinics
6.4. Others
7. Global Cardiac Marker Testing Market, by Region
7.1. North America
7.1.1. United States
7.1.2. Canada
7.1.3. Mexico
7.2. Europe
7.2.1. Germany
7.2.2. United Kingdom
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Netherlands
7.2.7. Switzerland
7.2.8. Sweden
7.2.9. Rest of Europe
7.3. Asia Pacific
7.3.1. China
7.3.2. Japan
7.3.3. India
7.3.4. South Korea
7.3.5. Australia
7.3.6. Singapore
7.3.7. Malaysia
7.3.8. Thailand
7.3.9. Vietnam
7.3.10. Rest of Asia Pacific
7.4. Latin America
7.4.1. Brazil
7.4.2. Argentina
7.4.3. Rest of Latin America
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. South Africa
7.5.3. Rest of Middle East and Africa
8. Competitive Landscape
8.1. Market Share Analysis
8.2. Company Profiles
8.2.1. Roche Holding AG
8.2.2. Abbott Laboratories
8.2.3. Thermo Fisher Scientific Inc.
8.2.4. Siemens Healthineers
8.2.5. Bio-Rad Laboratories, Inc.
8.2.6. Danaher Corporation
8.2.7. Ortho Clinical Diagnostics
8.2.8. QIAGEN N.V.
8.2.9. Hologic, Inc.
8.2.10. Grifols S.a.
9. Conclusion and Future Outlook10. Appendix
List of Tables
Table 1: Global Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 2: Global Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 3: Global Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 4: North America Cardiac Marker Testing Market Value by Country, 2022-2030 (USD Million)
Table 5: United States Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 6: United States Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 7: United States Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 8: Canada Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 9: Canada Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 10: Canada Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 11: Mexico Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 12: Mexico Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 13: Mexico Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 14: Europe Cardiac Marker Testing Market Value by Country, 2022-2030 (USD Million)
Table 15: Germany Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 16: Germany Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 17: Germany Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 18: United Kingdom Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 19: United Kingdom Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 20: United Kingdom Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 21: France Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 22: France Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 23: France Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 24: Italy Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 25: Italy Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 26: Italy Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 27: Spain Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 28: Spain Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 29: Spain Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 30: Russia Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 31: Russia Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 32: Russia Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 33: Rest of Europe Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 34: Rest of Europe Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 35: Rest of Europe Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 36: Asia Pacific Cardiac Marker Testing Market Value by Country, 2022-2030 (USD Million)
Table 37: China Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 38: China Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 39: China Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 40: Japan Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 41: Japan Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 42: Japan Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 43: India Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 44: India Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 45: India Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 46: Australia Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 47: Australia Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 48: Australia Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 49: South Korea Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 50: South Korea Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 51: South Korea Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 52: ASEAN Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 53: ASEAN Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 54: ASEAN Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 55: Rest of Asia-Pacific Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 56: Rest of Asia-Pacific Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 57: Rest of Asia-Pacific Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 58: MEA Cardiac Marker Testing Market Value by Country, 2022-2030 (USD Million)
Table 59: Turkey Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 60: Turkey Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 61: Turkey Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 62: Saudi Arabia Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 63: Saudi Arabia Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 64: Saudi Arabia Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 65: UAE Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 66: UAE Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 67: UAE Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 68: South Africa Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 69: South Africa Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 70: South Africa Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 71: Rest of MEA Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 72: Rest of MEA Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 73: Rest of MEA Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 74: South America Cardiac Marker Testing Market Value by Country, 2022-2030 (USD Million)
Table 75: Brazil Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 76: Brazil Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 77: Brazil Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 78: Argentina Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 79: Argentina Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 80: Argentina Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 81: Rest of South America Cardiac Marker Testing Market Value by Product, 2022-2030 (USD Million)
Table 82: Rest of South America Cardiac Marker Testing Market Value by Marker Type, 2022-2030 (USD Million)
Table 83: Rest of South America Cardiac Marker Testing Market Value by End-User, 2022-2030 (USD Million)
Table 84: Company Regional Footprint
Table 85: Company Industry Footprint
List of Figures
Figure 1: Global Cardiac Marker Testing Market Segments
Figure 2: Research Timelines
Figure 3: Data Triangulation Method
Figure 4: Market Research Flow
Figure 5: Data Sources
Figure 6: Executive Summary
Figure 7: Global Cardiac Marker Testing Market Estimates and Forecast (USD Million), 2022-2031
Figure 8: Global Cardiac Marker Testing Market Absolute Market Opportunity
Figure 9: Global Cardiac Marker Testing Market Attractiveness Analysis, by Region
Figure 10: Global Cardiac Marker Testing Market Attractiveness Analysis, by Product
Figure 11: Global Cardiac Marker Testing Market Attractiveness Analysis, by Marker Type
Figure 12: Global Cardiac Marker Testing Market Attractiveness Analysis, by End-User
Figure 13: Global Cardiac Marker Testing Market Geographical Analysis, 2024-2031
Figure 14: Global Cardiac Marker Testing Market, by Product (USD Million)
Figure 15: Global Cardiac Marker Testing Market, by Marker Type (USD Million)
Figure 16: Global Cardiac Marker Testing Market, by End-User (USD Million)
Figure 17: Future Market Opportunities
Figure 18: Global Cardiac Marker Testing Market Outlook
Figure 19: Porter's Five Forces Analysis
Figure 20: Global Cardiac Marker Testing Market, by Product
Figure 21: Global Cardiac Marker Testing Market Basis Point Share (BPS) Analysis, by Product
Figure 22: Global Cardiac Marker Testing Market, by Marker Type
Figure 23: Global Cardiac Marker Testing Market Basis Point Share (BPS) Analysis, by Marker Type
Figure 24: Global Cardiac Marker Testing Market, by End-User
Figure 25: Global Cardiac Marker Testing Market Basis Point Share (BPS) Analysis, by End-User
Figure 26: Global Cardiac Marker Testing Market, by Geography, 2022-2031 (USD Million)
Figure 27: North America Market Snapshot
Figure 28: U.S. Market Snapshot
Figure 29: Canada Market Snapshot
Figure 30: Mexico Market Snapshot
Figure 31: Europe Market Snapshot
Figure 32: Germany Market Snapshot
Figure 33: UK Market Snapshot
Figure 34: France Market Snapshot
Figure 35: Italy Market Snapshot
Figure 36: Russia Market Snapshot
Figure 37: Spain Market Snapshot
Figure 38: Rest of Europe Market Snapshot
Figure 39: Asia-Pacific Market Snapshot
Figure 40: China Market Snapshot
Figure 41: India Market Snapshot
Figure 42: Japan Market Snapshot
Figure 43: Australia Market Snapshot
Figure 44: South Korea Market Snapshot
Figure 45: ASEAN Market Snapshot
Figure 46: Rest of Asia-Pacific Market Snapshot
Figure 47: MEA Market Snapshot
Figure 48: Turkey Market Snapshot
Figure 49: UAE Market Snapshot
Figure 50: Saudi Arabia Market Snapshot
Figure 51: South Africa Market Snapshot
Figure 52: Rest of MEA Market Snapshot
Figure 53: South America Market Snapshot
Figure 54: Brazil Market Snapshot
Figure 55: Argentina Market Snapshot
Figure 56: Rest of South America Market Snapshot
Figure 57: Company Market Ranking Analysis
Figure 58: Ace Matrix
Figure 59: Roche Holding AG - Company Insights
Figure 60: Roche Holding AG - Segment Breakdown
Figure 61: Roche Holding AG - SWOT Analysis
Figure 62: Abbott Laboratories - Company Insights
Figure 63: Abbott Laboratories - Segment Breakdown
Figure 64: Abbott Laboratories - SWOT Analysis
Figure 65: Thermo Fisher Scientific Inc. - Company Insights
Figure 66: Thermo Fisher Scientific Inc. - Segment Breakdown
Figure 67: Thermo Fisher Scientific Inc. - SWOT Analysis
Figure 68: Siemens Healthineers - Company Insights
Figure 69: Siemens Healthineers - Segment Breakdown
Figure 70: Siemens Healthineers - SWOT Analysis
Figure 71: Bio-Rad Laboratories, Inc. - Company Insights
Figure 72: Bio-Rad Laboratories, Inc. - Segment Breakdown
Figure 73: Bio-Rad Laboratories, Inc. - SWOT Analysis
Figure 74: Danaher Corporation - Company Insights
Figure 75: Danaher Corporation - Segment Breakdown
Figure 76: Danaher Corporation - SWOT Analysis
Figure 77: Ortho Clinical Diagnostics - Company Insights
Figure 78: Ortho Clinical Diagnostics - Segment Breakdown
Figure 79: Ortho Clinical Diagnostics - SWOT Analysis
Figure 80: QIAGEN N.V. - Company Insights
Figure 81: QIAGEN N.V. - Segment Breakdown
Figure 82: QIAGEN N.V. - SWOT Analysis
Figure 83: Hologic, Inc. - Company Insights
Figure 84: Hologic, Inc. - Segment Breakdown
Figure 85: Hologic, Inc. - SWOT Analysis
Figure 86: Grifols S.a. - Company Insights
Figure 87: Grifols S.a. - Segment Breakdown
Figure 88: Grifols S.a. - SWOT Analysis

Companies Mentioned

  • Roche Holding AG
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Ortho Clinical Diagnostics
  • QIAGEN N.V.
  • Hologic Inc.
  • Grifols S.A.

Related Topics

Related Reports

Cardiac Marker Testing Market by Biomarker (Troponin, CK-MB, BNP, hs-CRP, Myoglobin), Product (Instrument (Chemiluminescence, ELISA), Reagents & Kits), Disease (MI, CHF, Atherosclerosis), User, ASP & Buying Criteria - Global Forecast to 2028 - Product Image

Cardiac Marker Testing Market by Biomarker (Troponin, CK-MB, BNP, hs-CRP, Myoglobin), Product (Instrument (Chemiluminescence, ELISA), Reagents & Kits), Disease (MI, CHF, Atherosclerosis), User, ASP & Buying Criteria - Global Forecast to 2028

  • Report
  • 216 Pages
  • Global
From
Global Cardiac Marker Testing Market by Product (Instruments, Reagents & Kits), Biomarker (BNP Or NT-ProBNP, Ceratine Kinase-MB, hs-CRP), Type of Testing, Disease - Forecast 2024-2030 - Product Image

Global Cardiac Marker Testing Market by Product (Instruments, Reagents & Kits), Biomarker (BNP Or NT-ProBNP, Ceratine Kinase-MB, hs-CRP), Type of Testing, Disease - Forecast 2024-2030

  • Report
  • 195 Pages
  • Global
From
Global Cardiac Marker Market by Product (Instruments, Reagents & Kits), Biomarker Type (BNP Or NT-ProBNP, CK-MB, Hs-CRP), End-User, Indication - Forecast 2024-2030 - Product Image

Global Cardiac Marker Market by Product (Instruments, Reagents & Kits), Biomarker Type (BNP Or NT-ProBNP, CK-MB, Hs-CRP), End-User, Indication - Forecast 2024-2030

  • Report
  • 189 Pages
  • Global
From
Global Cardiac Marker Testing Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Global Cardiac Marker Testing Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 155 Pages
  • Global
From
Cardiac Marker Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Cardiac Marker Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 187 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.